I have been recently diagnosed with IBC, stage 3B, only one side was affected. I have started my AC portion of cemo therapy, just completed 1 cycle. Now, I'me not sure how I'll handle the rest of it?, I'll just take it one step at a time.
I heard about some research that can be used to design treatments that can optimally attack the patient specific tumors--based on genetic make up--identified from testing on samples extracted from the patient cancerous locations. This make sense to me-- cancer is normally initiated through mutated genes or default in switching mechanism, and developing drugs to target the cancer instead of the healthy cells as well, would be the only option for less painful treatment for cancer. Once treatment is planned, bio-markers from the patient need to be monitored in real time, to confirm the expected responses and destruction of the tumors in the real patient environment. I'm very optimistic, and hopefully a true treatment customized for each patient will become available real soon.
I understand that this is currently in research, but I can't understand why people working this research, through FDA compliance, can't work with real patients at each patient level, instead of just following the current ways - through initiating clinical trials and come up by statistical figures to approve treatments or drugs across relatively diverse pool of volunteers. For me, I don't like to be just a statistical numer--ginny peg, to prove some one's research point, related to a narrow scope or time for treatment. I would like to have the flexibility to have a knowledgeable researcher track my responses and tune the treatment to my own specific issues as they arise.
Unfortunately, current FDA policy for drug certification, doesn't address specific needs for each patient, Instead rules for approval of new treatments are based on demonstrating some statistics, regardless of variations among all participants involved in clinical trials.
I strongly believe there are enough research done that way, and now is the time to put this research for use, and transition into patient-integrated environment, that focuses on treatments for each patient, and tune treatment based on each patient's response. I'm hopeful this can get us more closer into real treatments for cancer.
I was wondering if any one have gone through this path, or even welling to work with me the details to allow for true solutions for cancer treatment, and work the necessary governmental policies to make this happen.